Jacques Lelorier - Publications

Affiliations: 
Biomedical Sciences Université de Montréal, Montréal, Canada 
Area:
Oncology, Public Health, Microbiology Biology

31 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Samuel M, Tardif JC, Khairy P, Roubille F, Waters DD, Grégoire JC, Pinto FJ, Maggioni AP, Diaz R, Berry C, Koenig W, Ostadal P, Lopez-Sendon J, Gamra H, Kiwan GS, ... ... Lelorier J, et al. Cost-Effectiveness of Low-Dose Colchicine after Myocardial Infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT). European Heart Journal. Quality of Care & Clinical Outcomes. PMID 32407460 DOI: 10.1093/Ehjqcco/Qcaa045  0.321
2018 Mitchell D, Guertin JR, Dubois A, Dubé MP, Tardif JC, Iliza AC, Fanton-Aita F, Matteau A, LeLorier J. A Discrete Event Simulation Model to Assess the Economic Value of a Hypothetical Pharmacogenomics Test for Statin-Induced Myopathy in Patients Initiating a Statin in Secondary Cardiovascular Prevention. Molecular Diagnosis & Therapy. PMID 29651791 DOI: 10.1007/S40291-018-0323-2  0.308
2017 Perrault L, Dahan S, Iliza AC, LeLorier J, Zhanel GG. Cost-Effectiveness Analysis of Fosfomycin for Treatment of Uncomplicated Urinary Tract Infections in Ontario. The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien Des Maladies Infectieuses Et De La Microbiologie Medicale. 2017: 6362804. PMID 28316632 DOI: 10.1155/2017/6362804  0.303
2016 Mitchell D, Guertin JR, Iliza AC, Fanton-Aita F, LeLorier J. Economic Evaluation of a Pharmacogenomics Test for Statin-Induced Myopathy in Cardiovascular High-Risk Patients Initiating a Statin. Molecular Diagnosis & Therapy. PMID 27798813 DOI: 10.1007/S40291-016-0238-8  0.312
2016 Iliza AC, Matteau A, Guertin JR, Mitchell D, Fanton-Aita F, Dubois A, Dubé MP, Tardif JC, LeLorier J. A model to assess the cost-effectiveness of pharmacogenomics tests in chronic heart failure: the case of ivabradine. Pharmacogenomics. PMID 27719379 DOI: 10.2217/Pgs-2016-0054  0.346
2016 Abrahamowicz M, Bjerre LM, Beauchamp ME, LeLorier J, Burne R. The missing cause approach to unmeasured confounding in pharmacoepidemiology. Statistics in Medicine. 35: 1001-16. PMID 26932124 DOI: 10.1002/Sim.6818  0.325
2015 Perrault L, Fradet V, Lauzon V, LeLorier J, Mitchell D, Habib M. Burden of illness of bone metastases in prostate cancer patients in Québec, Canada: A population-based analysis. Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada. 9: 307-14. PMID 26664661 DOI: 10.5489/Cuaj.2707  0.55
2015 Perrault L, Fradet V, Lauzon V, Lelorier J, Mitchell D, Habib M. Burden of illness of bone metastases in prostate cancer patients in Québec, Canada: A population-based analysis Journal of the Canadian Urological Association. 9: 307-314. DOI: 10.5489/cuaj.2707  0.504
2008 Chabot I, LeLorier J, Blackstein ME. The challenge of conducting pharmacoeconomic evaluations in oncology using crossover trials: the example of sunitinib for gastrointestinal stromal tumour. European Journal of Cancer (Oxford, England : 1990). 44: 972-7. PMID 18372169 DOI: 10.1016/J.Ejca.2008.02.041  0.313
2008 Sheehy O, LeLorier J, Rinfret S. Restrictive access to clopidogrel and mortality following coronary stent implantation. Cmaj : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne. 178: 413-20. PMID 18268267 DOI: 10.1503/Cmaj.070586  0.302
2006 Monfared AAT, Han D, Sheeny O, Bexton B, LeLorier J. Assessment of Canadian provincial expenditures in depressed patients treated with venlafaxine XR versus SSRIs: The APEX Study Current Medical Research and Opinion. 22: 83-94. PMID 16393434 DOI: 10.1185/030079906X80314  0.317
2005 Gueylard Chenevier D, LeLorier J. A willingness-to-pay assessment of parents' preference for shorter duration treatment of acute otitis media in children. Pharmacoeconomics. 23: 1243-55. PMID 16336018 DOI: 10.2165/00019053-200523120-00008  0.699
2005 Quach C, Collet JP, LeLorier J. Effectiveness of amoxicillin, azithromycin, cefprozil and clarithromycin in the treatment of acute otitis media in children: a population-based study. Pharmacoepidemiology and Drug Safety. 14: 163-70. PMID 15386697 DOI: 10.1002/Pds.991  0.321
2004 Quach C, Collet JP, LeLorier J. Acute otitis media in children: a retrospective analysis of physician prescribing patterns. British Journal of Clinical Pharmacology. 57: 500-5. PMID 15025749 DOI: 10.1111/J.1365-2125.2003.02019.X  0.324
2004 Blais L, Bourbeau J, Sheehy O, LeLorier J. Inhaled corticosteroids in COPD: determinants of use and trends in patient persistence with treatment. Canadian Respiratory Journal : Journal of the Canadian Thoracic Society. 11: 27-32. PMID 15010729 DOI: 10.1155/2004/289420  0.328
2003 Houde M, Castilloux AM, Tingey D, Assalian A, LeLorier J. Prescription of topical antiglaucoma agents for patients with contraindications to beta-blockers. Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie. 38: 469-75. PMID 14620034 DOI: 10.1016/S0008-4182(03)80025-X  0.321
2003 Tahami Monfared A, Gueylard Chenevier D, Lescrauwaet B, LeLorier J. PMH7: A MARKOV COHORT SIMULATION ESTIMATING THE RISK OF DEVELOPING CORONARY HEART DISEASE IN PATIENTS USING ANTIPSYCHOTIC DRUGS Value in Health. 6: 344. DOI: 10.1016/S1098-3015(10)64209-X  0.691
2003 Gueylard Chenevier D, Quach C, Dorais M, LeLorier J. PIN48: ASSESSING PARENTS' PREFERENCE FOR A UNIQUE ANTIBIOTIC DOSE IN THE TREATMENT OF ACUTE OTITIS MEDIA IN CHILDREN BY USING A WILLINGNESS TO PAY METHOD Value in Health. 6: 269. DOI: 10.1016/S1098-3015(10)64025-9  0.699
2002 Rahme E, Pettitt D, LeLorier J. Determinants and sequelae associated with utilization of acetaminophen versus traditional nonsteroidal antiinflammatory drugs in an elderly population. Arthritis and Rheumatism. 46: 3046-54. PMID 12428249 DOI: 10.1002/Art.10604  0.344
2001 Bjerre LM, LeLorier J. Do statins cause cancer? A meta-analysis of large randomized clinical trials American Journal of Medicine. 110: 716-723. PMID 11403756 DOI: 10.1016/S0002-9343(01)00705-7  0.306
2001 Catalan VS, Couture JA, Lelorier J. Predictors of persistence of use of the novel antidiabetic agent acarbose Archives of Internal Medicine. 161: 1106-1112. PMID 11322845 DOI: 10.1001/Archinte.161.8.1106  0.31
2000 Catalan VS, Lelorier J. Predictors of long-term persistence on statins in a subsidized clinical population Value in Health. 3: 417-426. PMID 16464201 DOI: 10.1046/J.1524-4733.2000.36006.X  0.335
2000 Bjerre LM, LeLorier J. Expressing the magnitude of adverse effects in case-control studies: 'The number of patients needed to be treated for one additional patient to be harmed' British Medical Journal. 320: 503-506. PMID 10678870 DOI: 10.1136/Bmj.320.7233.503  0.317
1999 Desgagné A, LeLorier J. Incontinence Drug Utilization Patterns in Québec, Canada Value in Health. 2: 452-458. PMID 16674332 DOI: 10.1046/J.1524-4733.1999.26005.X  0.335
1998 Desgagne A, Castilloux AM, Angers JF, LeLorier J. The use of the bootstrap statistical method for the pharmacoeconomic cost analysis of skewed data Pharmacoeconomics. 13: 487-497. PMID 10180748 DOI: 10.2165/00019053-199813050-00002  0.311
1998 Garbe E, Suissa S, Lelorier J. Association of inhaled corticosteroid use with cataract extraction in elderly patients Journal of the American Medical Association. 280: 539-543. PMID 9707144 DOI: 10.1001/Jama.280.6.539  0.319
1998 Avorn J, Monette J, Lacour A, Bohn RL, Monane M, Mogun H, LeLorier J. Persistence of use of lipid-lowering medications: A cross-national study Journal of the American Medical Association. 279: 1458-1462. PMID 9600480 DOI: 10.1001/Jama.279.18.1458  0.332
1997 LeLorier J, Pagé V, Castilloux AM, LeLorier Y. Management of new symptoms of dyspepsia in the elderly in Quebec Canadian Journal of Gastroenterology. 11: 669-672. PMID 9459046 DOI: 10.1155/1997/395236  0.316
1997 Garbe E, LeLorier J, Boivin JF, Suissa S. Risk of ocular hypertension or open-angle glaucoma in elderly patients on oral glucocorticoids Lancet. 350: 979-982. PMID 9329512 DOI: 10.1016/S0140-6736(97)03392-8  0.309
1997 Garbe E, LeLorier J, Boivin J, Suissa S. Inhaled and Nasal Glucocorticoids and the Risks of Ocular Hypertension or Open-angle Glaucoma Jama. 277: 722-727. DOI: 10.1001/Jama.1997.03540330044033  0.306
1996 Gong L, Zhang W, Zhu Y, Zhu J, Kong D, Pagé V, Ghadirian P, LeLorier J, Hamet P. Shanghai trial of nifedipine in the elderly (STONE) Journal of Hypertension. 14: 1237-1245. PMID 8906524 DOI: 10.1097/00004872-199610000-00013  0.307
Show low-probability matches.